GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The FDA and EMA's joint guidance was created to ensure the pharmaceutical industry employs best practices when using AI in ...
Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...
In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback